Consilio Wealth Advisors LLC Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

Consilio Wealth Advisors LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 951 shares of the healthcare conglomerate’s stock after selling 22 shares during the period. Consilio Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $481,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $27,000. Global Wealth Strategies & Associates increased its holdings in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $32,000. Quarry LP increased its holdings in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $541.28 on Tuesday. The stock has a market cap of $498.13 billion, a price-to-earnings ratio of 35.26, a PEG ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock’s 50 day moving average price is $554.92 and its 200 day moving average price is $562.88. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the company earned $6.56 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.